نتایج جستجو برای: therapy response

تعداد نتایج: 1550012  

Journal: :hepatitis monthly 0
marwa khairy endemic medicine department and hepatology unit, faculty of medicine, cairo university, cairo, egypt rabab fouad endemic medicine department and hepatology unit, faculty of medicine, cairo university, cairo, egypt mahassen mabrouk endemic medicine department and hepatology unit, faculty of medicine, cairo university, cairo, egypt wafaa el-akel endemic medicine department and hepatology unit, faculty of medicine, cairo university, cairo, egypt abu bakr awad bioinformatic and statistic department, faculty of computer sciences, cairo university, cairo, egypt rabab salama endemic medicine department and hepatology unit, faculty of medicine, cairo university, cairo, egypt; endemic medicine and hepatology department, kasr el-aini faculty of medicine, cairo university, cairo, egypt. tel: +20-25262555, fax: +20-25326439

conclusions: absence of the c allele was significantly associated with failure of response. the presence of c allele was associated with a favorable outcome. afp is a strong baseline predictor of hcv treatment response. a decision tree model is useful for predicting the probability of response to therapy. patients and methods: the study included 263 chronic hcv egyptian patients receiving peg-i...

Journal: :medical journal of islamic republic of iran 0
taleb azarm from the division of hematology /medical oncology. seyyed-al shohada hospital, isfahan university of medical sciences. isfahan, islamic republic of iran.

twenty-one patients with advanced breast cancer (7 premenopausal and 14 postmenopausal women) were treated with a combination of cyclophosphamide, doxorubicin, and cisplatin (cap). the median age of the patients was 43 years (range 36-61). this therapy was repeated every 3 weeks. nine patients (group 1) received cap as primary therapy for metastatic breast cancer, and twelve patients (group 2) ...

بافنده , یوسف, باقری لنکرانی , کامران, صابری فیروزی , مهدی,

Background and purpose: About 200,000 of Iranian population are infected with Hepatitis C Virus. On the basis of Iranian consensus on management of chronic hepatitis C (CHC) infection in 2004, combination therapy with conventional α-Interferon (IFN) plus Ribavirin is the first therapeutic choice in CHC patients. Data are limited on treatment response rate in most areas of the country. To asse...

Journal: :hepatitis monthly 0
maryam keshvari blood transfusion research center, high institute for research and education in transfusion medicine,tehran, ir iran; middle east liver disease (meld) center, tehran, ir iran seyed moayed alavian middle east liver disease (meld) center, tehran, ir iran; middle east liver disease (meld) center, tehran, ir iran. tel: +98-2188945186, fax: +98-2188945188 heidar sharafi middle east liver disease (meld) center, tehran, ir iran gharib karimi blood transfusion research center, high institute for research and education in transfusion medicine,tehran, ir iran mohammad gholami fesharaki department of biostatistics, school of medical sciences, tarbiat modares university, tehran, ir iran

results overall, 3 (15%) subjects achieved svr, 10 cases (50%) relapsed after treatment cessation and 7 (35%) patients did not clear hdv during the treatment. conclusions hdv coinfection with hbv had very low response rate to high doses and long durations of ifn α-2b therapy. objectives we aimed to determine the efficacy of ifn α-2b therapy in patients with hbv/hdv coinfection. patients and met...

Hossein Assadian,

The therapeutic efficacy of the combination of cyproheptadine and bromocriptine was studied in 15 patients with active acromegaly showing incomplete GH suppression in response to bromocriptine therapy alone. The mean basal plasma GH was 31.3±5.5 µg/L, and it decreased to 19.0±3.9 µg/L during the single bromocriptine therapy (10-20 mg for 2 to 21 months). When cyproheptadine (12 to 16 mg for 8 t...

Journal: :Mayo Clinic Proceedings 1995

TALEB AZARM,

Twenty-one patients with advanced breast cancer (7 premenopausal and 14 postmenopausal women) were treated with a combination of cyclophosphamide, doxorubicin, and cisplatin (CAP). The median age of the patients was 43 years (range 36-61). This therapy was repeated every 3 weeks. Nine patients (group 1) received CAP as primary therapy for metastatic breast cancer, and twelve patients (group...

Journal: :Seminars in Nuclear Medicine 2018

Journal: :Mayo Clinic Proceedings 1996

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه شیراز - دانشکده دندانپزشکی 1380

چکیده ندارد.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید